TY - JOUR
T1 - Conclusions and recommendations from the symposium, Beyond Cholesterol
T2 - Prevention and Treatment of Coronary Heart Disease with n-3 Fatty Acids
AU - Deckelbaum, Richard J.
AU - Leaf, Alexander
AU - Mozaffarian, Dariush
AU - Jacobson, Terry A.
AU - Harris, William S.
AU - Akabas, Sharon R.
PY - 2008/6/1
Y1 - 2008/6/1
N2 - After the symposium "Beyond Cholesterol: Prevention and Treatment of Coronary Heart Disease with n-3 Fatty Acids," faculty who presented at the conference submitted manuscripts relating to their conference topics, and these are presented in this supplement. The content of these manuscripts was reviewed, and 2 conference calls were convened. The objective was to summarize existing evidence, gaps in evidence, and future research needed to strengthen recommendations for specific intakes of n-3 fatty acids for different conditions relating to cardiovascular disease. The following 2 questions were the main items discussed. What are the roles of n-3 fatty acids in primary versus secondary prevention of coronary heart disease? What are the roles of n-3 fatty acids in hypertriglyceridemia, in the metabolic syndrome and type 2 diabetes, and in sudden cardiac death, cardiac arrhythmias, and vulnerable plaque? Each area was summarized by using 2 general categories: 1) current knowledge for which general consensus exists, and 2) recommendations for research and policy. Additional references for these conclusions can be found in the articles included in the supplement.
AB - After the symposium "Beyond Cholesterol: Prevention and Treatment of Coronary Heart Disease with n-3 Fatty Acids," faculty who presented at the conference submitted manuscripts relating to their conference topics, and these are presented in this supplement. The content of these manuscripts was reviewed, and 2 conference calls were convened. The objective was to summarize existing evidence, gaps in evidence, and future research needed to strengthen recommendations for specific intakes of n-3 fatty acids for different conditions relating to cardiovascular disease. The following 2 questions were the main items discussed. What are the roles of n-3 fatty acids in primary versus secondary prevention of coronary heart disease? What are the roles of n-3 fatty acids in hypertriglyceridemia, in the metabolic syndrome and type 2 diabetes, and in sudden cardiac death, cardiac arrhythmias, and vulnerable plaque? Each area was summarized by using 2 general categories: 1) current knowledge for which general consensus exists, and 2) recommendations for research and policy. Additional references for these conclusions can be found in the articles included in the supplement.
UR - http://www.scopus.com/inward/record.url?scp=45749117117&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=45749117117&partnerID=8YFLogxK
U2 - 10.1093/ajcn/87.6.2010s
DO - 10.1093/ajcn/87.6.2010s
M3 - Article
C2 - 18541603
AN - SCOPUS:45749117117
SN - 0002-9165
VL - 87
SP - 2010S-2012S
JO - American Journal of Clinical Nutrition
JF - American Journal of Clinical Nutrition
IS - 6
ER -